Equillium (EQ)
Develops EQ504, an investigational AhR modulator for ulcerative colitis and other inflammatory diseases.
$2.20
Pre-market−0.06 (−2.65%)
At close$2.26(+2.49%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions52 holders · as of Mar 31, 2026 | 63.87% | 40.50M shares | |
| Insiders3 holders · as of Jun 5, 2026 | 1.50% | 951.2K shares | |
| Strategic holders1 holder · as of May 15, 2026 | 6.74% | 4.27M shares | |
| Otherremainder | 27.89% | 17.69M shares |
63.41M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
52 holders · 40.50M shares · 18 new positions · 28 increased · 11 reduced · 6 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Janus Henderson Group PLC | 6.49M | 10.24% | +632.4K | May 18, 2026 |
| Adage Capital Partners GP, L.L.C. | 5.33M | 8.40% | 0 | May 15, 2026 |
| Decheng Capital LLC | 4.45M | 7.01% | 0 | May 13, 2026 |
| Adar1 Capital Management, LLC | 3.73M | 5.88% | −1.88M | May 18, 2026 |
| Woodline Partners LP | 3.50M | 5.52% | 0 | May 15, 2026 |
| Abrdn PLC | 3.35M | 5.29% | +986.1K | Apr 29, 2026 |
| Ra Capital Management, L.P. | 3.10M | 4.88% | +3.10Mnew | May 15, 2026 |
| Vanguard Capital Management LLC | 1.78M | 2.81% | +1.78Mnew | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Janus Henderson Group PLC | 9.99% | 6.08M | 13G | Feb 6, 2026 ↗ |
| Adage Capital Management, L.P. | 9.99% | 6.01M | 13G | Nov 13, 2025 ↗ |
| ADAR1 Capital Management, LLC | 9.90% | 6.60M | 13G | May 15, 2026 ↗ |
| RA Capital Management, L.P. | 9.90% | 6.48M | 13G | Mar 20, 2026 ↗ |
| Decheng Capital Management IV (Cayman), LLC | 6.70% | 4.27M | 13G | May 15, 2026 ↗ |
| Affinity Asset Advisors, LLC | 6.50% | 4.10M | 13G | Aug 13, 2026 ↗ |
| Woodline Partners LP | 5.90% | 3.51M | 13G | Nov 14, 2025 ↗ |
| Aberdeen Group plc | 5.30% | 3.35M | 13G | May 7, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 5, 2026 | Stephen Connellyofficer: President and CSO | Sale | 30,975 | $2.94 | 762,025 |
| Jun 4, 2026 | Stephen Connellyofficer: President and CSO | Sale | 200,000 | $3.16 | 793,000 |
| Jun 5, 2026 | Christine Zedelmayerofficer: Sr. Vice President and COO | Sale | 14,584 | $2.93 | 62,586 |
| May 27, 2026 | Christine Zedelmayerofficer: Sr. Vice President and COO | Sale | 9,821 | $2.70 | 62,586 |
| May 28, 2026 | Christine Zedelmayerofficer: Sr. Vice President and COO | Sale · 3 lots | 86,012 | $2.80 | 62,586 |
| May 28, 2026 | Penny Tomofficer: Principal Accounting Officer | Sale | 65,000 | $2.95 | 0 |
| Mar 13, 2026 | Christine Zedelmayerofficer: Sr. Vice President and COO | Sale | 120,312 | $2.50 | 62,586 |
| Mar 9, 2026 | Christine Zedelmayerofficer: Sr. Vice President and COO | Sale | 181,219 | $2.00 | 62,586 |
| Feb 19, 2026 | Christine Zedelmayerofficer: Sr. Vice President and COO | Sale · 2 lots | 185,937 | $1.76 | 91,444 |
| Jan 8, 2026 | Penny Tomofficer: Principal Accounting Officer | Sale | 6,533 | $1.29 | 0 |
CongressHouse and Senate disclosures
Not reported.
